Malignant melanoma is the fastest-growing and 7th ... (which may be pigmented as in acne scars after prolonged minocycline treatment), and seborrheic keratoses. The multidisciplinary team may ...

Although patients with metastatic melanoma fare poorly ... determining natural history and outcomes of older melanoma patients following treatment. Immune-based treatment strategies continue ...

Breast cancer that has spread to other parts of your body may start to cause new symptoms, depending on the location of the metastases. As symptoms develop or progress, treatment and care may also ...

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...

During a Case-Based Roundtable meeting, Lipson and participants talked about the complexity of choosing the right therapy for ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute ...

FDA approved for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma that is not ...